VSV-EBOV vaccine is effective in monkeys against Ebola virus
The live-attenuated vaccine, VSV-EBOV, uses genetically engineered Vesicular stomatitis virus to carry an EBOV gene that has safely induced protective immunity in Cynomolgus macaques (monkey) against EBOV-Makona (virus) strain. The experimental vaccine is currently undergoing testing in a global clinical trial in humans.
Ref: A Marzi et al., 2015, Science.
